文献速递头痛与眩晕

基于共病亚组的偏头痛进展:CaMEO研究结果

Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
PubMed 文献 · Neurology · 2019-11-05

该研究基于CaMEO研究数据,检验基于共病情境定义的偏头痛亚组在预后(即从发作性偏头痛进展为慢性偏头痛的比率)上是否存在差异。研究在12个月内最多评估4次慢性偏头痛的发作,纳入完成至少1次随访调查的发作性偏头痛且基线有至少1种共病的个体。结果发现,与共病最少的类别相比,所有共病类别进展为慢性偏头痛的风险比均显著升高,风险比范围从5.34(95%CI 3.89-7.33;p≤0.001)到1.53(95%CI 1.17-2.01;p<0.05),且在独立调整头痛协变量后,每个共病类别仍显著预测慢性偏头痛发作,尽管风险比有所衰减。

要点

  • 基于共病类别划分的偏头痛亚组可预测从发作性偏头痛进展为慢性偏头痛。
  • 与共病最少的类别相比,所有共病类别进展为慢性偏头痛的风险比均显著升高。
  • 调整头痛严重程度指标(如MIDAS)后,共病类别与慢性偏头痛发作的关系仍然存在。

核心结论

  • 基于共病类别在横断面上识别的偏头痛亚组可预测从发作性偏头痛(基线至少1种共病)进展为慢性偏头痛。
  • 在调整偏头痛严重程度指标(如MIDAS)后,共病组与慢性偏头痛发作的关系仍然存在。

研究设计与样本

  • 研究利用CaMEO研究数据,在12个月内最多4次评估慢性偏头痛的发作。
  • 纳入完成至少1次随访调查的发作性偏头痛且基线有至少1种共病的个体,以共病最少的类别作为参照。

主要发现

  • 在最终社会人口学模型中,所有共病类别相对于共病最少类别,进展为慢性偏头痛的风险比均显著升高。
  • 慢性偏头痛发作的风险比范围从5.34(95%CI 3.89-7.33;p≤0.001)到1.53(95%CI 1.17-2.01;p<0.05)。
  • 独立调整头痛协变量后,每个共病类别仍显著预测慢性偏头痛发作,但风险比有所衰减。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the hypothesis that statistically defined subgroups of migraine (based on constellations of comorbidities and concomitant conditions; henceforth comorbidities), previously identified using Chronic Migraine Epidemiology and Outcomes (CaMEO) Study data, differ in prognosis, as measured by rates of progression from episodic migraine (EM) to chronic migraine (CM). METHODS: The onset of CM was assessed up to 4 times over 12 months in individuals with EM and ≥1 comorbidity at baseline, based on constellations of comorbidities (comorbidity classes). The "fewest comorbidities" class served as reference. Individuals completing ≥1 follow-up survey from the web-based CaMEO Study were included. Covariates included sociodemographic variables and headache characteristics. Sex, income, cutaneous allodynia, and medication overuse were modeled as binary variables; age, body mass index, headache-related disability (Migraine Disability Assessment [MIDAS]), and Migraine Symptom Severity Scale as continuous variables. CM onset was assessed using discrete time analysis. RESULTS: In the final sociodemographic model, all comorbidity classes had significantly elevated hazard ratios (HRs) for risk of progression to CM from EM, relative to fewest comorbidities. HRs for CM onset ranged from 5.34 (95% confidence interval [CI] 3.89-7.33; p ≤ 0.001) for most comorbidities to 1.53 (95% CI 1.17-2.01; p < 0.05) for the respiratory class. After adjusting for headache covariates independently, each comorbidity class significantly predicted CM onset, although HRs were attenuated. CONCLUSIONS: Subgroups of migraine identified by comorbidity classes at cross-section predicted progression from EM (with ≥1 comorbidity at baseline) to CM. The relationship of comorbidity group to CM onset remained after adjusting for indicators of migraine severity, such as MIDAS. CLINICALTRIALSGOV IDENTIFIER: NCT01648530.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Lipton RB, Fanning KM, Buse DC, et al. Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study. Neurology. 2019. PMID: 31690685. doi:10.1212/WNL.0000000000008589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。